| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 05/10/2005 | US6890932 Anthranilic acid derivative |
| 05/10/2005 | CA2097044C Cyclopentane- and -pentene-.beta.-amino acids |
| 05/06/2005 | WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 05/06/2005 | WO2005040146A1 Dihydrobenzofuranyl alkanamines and pharmaceutical compositions containing them |
| 05/06/2005 | WO2005040138A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | WO2005040132A1 Dicationic triaryl analogs as anti-protozoan agents |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | WO2005039552A2 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives |
| 05/06/2005 | WO2005039496A2 Inhibitors of cathepsin s |
| 05/06/2005 | WO2005027157A3 Salt fusible at ordinary temperature and electrochemical device |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | CA2543079A1 Dicationic triaryl analogs as anti-protozoan agents |
| 05/06/2005 | CA2542967A1 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives |
| 05/06/2005 | CA2542963A1 Inhibitors of cathepsin s |
| 05/06/2005 | CA2542695A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | CA2541472A1 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
| 05/05/2005 | US20050096477 Astaxanthin esters |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096389 Polyol ester compounds useful in preparation of a catalyst for olefins polymerization, process for preparing the same and use thereof |
| 05/05/2005 | US20050096361 and their carbamate-protected derivatives; Stereoselective synthesis from a 1-phenyl-2-(silyl)pentan-3-one and a toluensulfonylmethylcarbamate, cleavage of the oxycarbonyl; analgesic, anxiolytic , antidepressant; 5-(4-tert-butyl-phenyl)-1-isopropyl-2-methyl-3-oxo-pentyl]-carbamic acid benzyl ester |
| 05/05/2005 | US20050096358 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527777A1 Composition with antioxidant properties comprising an ester of ascorbic acid and a benzoyl rest |
| 05/04/2005 | EP1527034A1 A process for the optical resolution of a precursor of sclareolide |
| 05/04/2005 | EP1526861A2 Method for producing avocado leaves extract rich in furan lipids |
| 05/04/2005 | CN1199962C Anti-tumor medicine and use thereof |
| 05/04/2005 | CN1199961C Spliting method for DL-pantoyl intenral ester |
| 05/04/2005 | CN1199960C Agarofuran derivativs, their preparing process, medicinal composition containing them and their medicinal usage |
| 05/04/2005 | CN1199931C Naphthalene alizarine derivatives, preparing method and use thereof |
| 05/03/2005 | US6888032 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 05/03/2005 | US6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 05/03/2005 | US6888012 Reducing an alpha -haloketone compound by asymmetric hydrogen transfer in presence of a group 9 transition metal compound having a substituted or unsubstituted cyclopentadienyl group and an optically active diamine compound |
| 05/03/2005 | US6888011 Porous catalyst for the hydrogenation of maleic anhydride to tetrahydrofuran |
| 05/03/2005 | US6888010 Process for the preparation of 5-formylphthalide |
| 05/03/2005 | US6888009 Method for the preparation of 5-carboxyphthalide |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | US6887281 N-heteroarylmethyl-p-phenylenediamine derivatives as well as oxidation dyeing agents containing these compounds |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 04/28/2005 | WO2005037840A1 Method for inverting the c2’ hydroxyl group of taxane esters |
| 04/28/2005 | WO2005037814A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 04/28/2005 | WO2005037813A1 A compound, the preparation and the use thereof |
| 04/28/2005 | WO2005037812A1 Furan derivatives as ep4 receptor antagonists |
| 04/28/2005 | WO2005037810A2 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | WO2005037786A1 Heterocyclyl compounds |
| 04/28/2005 | WO2005037760A1 Novel phenol derivatives and antitrypanosoma preventive/therapeutic agent containing the same as active ingredient |
| 04/28/2005 | WO2005037759A1 Novel phenol derivative and antitrypanosoma preventive/therapeutic agent containing the same as active ingredient |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037223A2 Methods and compositions for immunomodulation |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005019163A3 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090691 Halogen-containing aromatic acid dianhydride, halogen-containing aromatic tetranitrile compound, haltogen-containing aromatic tetracarbonxylic acid and halogen containing m-phenylenediamine compound, useful for raw materials of resins excellent in heat resistance, chemical resistance, water repellent |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090663 Carbonylation; hydrogenation; epoxidation; alkynylation; for preparation of eplerenone |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090514 Cool-genic compounds as anticarcinogenic agents promoting apoptosis and inhibit angiogenesis; antiproliferative agents |
| 04/28/2005 | US20050090487 Cardiovascular disorders; antiinflammatory agents |
| 04/28/2005 | US20050090469 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
| 04/28/2005 | US20050090400 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542440A1 Furan derivatives as ep4 receptor antagonists |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525235A1 Microstructure chain transfer agents for anionic polymerization |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1456193B1 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2 i H /i -DIBENZO 3,4:6,7]CYCLOHEPTA 1,2-b]FURAN DERIVATIVES |
| 04/27/2005 | EP1366033B1 Chemical compounds |
| 04/27/2005 | EP1011651B1 Method of treating diabetes and related disease states |
| 04/27/2005 | EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1 |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1198813C Benzofuran derivatives their preparation and use |
| 04/27/2005 | CN1198812C Process of preparing coarse vitamin C with glulconic acid |
| 04/27/2005 | CN1198811C Method for coupling preparation of gamma-butyrolactone and 2-methyl furan |
| 04/27/2005 | CN1198802C Chalcones having antiproliferactive activity |
| 04/27/2005 | CN1198793C Ethers of methyl venlafaxine |
| 04/27/2005 | CN1198610C Treatment of neurotic disorders |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884782 Amino acid containing compounds useful as modulators of the immune system |
| 04/26/2005 | US6884324 Column for concentrating phthalic anhydride |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 04/21/2005 | WO2005034936A1 Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |